In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Dilated cardiomyopathy and recurrent sustained ventricular tachycardia

by Maria Simonenko, Secondary Prevention and Rehabilitation Section et al.

Risk Factors and Prevention
Heart Failure


The case

A 37-year-old male had been described as a healthy individual until he got severe flu with prolonged fever and fast heart rate.

After that:

  • left ventricular ejection fraction (LVEF) decreased to 45%
  • left ventricular thrombus was revealed
  • Paroxysmal atrial fibrillation (AFib) was developed

Test your knowledge

 

Note: The views and opinions expressed on this page are those of the author and may not be accepted by others. While every attempt is made to keep the information up to date, there is always going to be a lag in updating information. The reader is encouraged to read this in conjunction with appropriate ESC Guidelines. The material on this page is for educational purposes and is not for use as a definitive management strategy in the care of patients. Quiz material on the site are only examples and do not guarantee outcomes from formal examinations.

References

  1. Theresa A. McDonagh et al. - 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, European Heart Journal, 2021: 1-128 DOI: 10.1093/eurheartj/ehab368
  2. Micahel Glikson et al. – 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy, European Heart Journal, 2021: 1-94 DOI: 10.1093/eurheartj.ehab364
  3. Silvia G. Priori et al. – 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, European Heart Journal, 2015; 35: 2793-2867 DOI: 10.1093/eurheartj/ehv316
  4. Prashant D. Bhave – Renal denervation therapy for the treatment of arrhythmias: is the Sky the Limit? JAHA, 2017; 6:e005341 DOI: 10.1161/JAHA.116.005342
  5. Jason S Bradfield et al. – Renal denervation as adjunctive therapy to cardiac sympathetic denervation for ablation refractory ventricular tachycardia, Heart Rhythm, 2020; 17(2): 220-227 DOI: 10.1016/j.hrthm.2019.09.016
  6. Jonathan S. Steinberg et al. – Effect of renal denervation and catheter ablation vs. catheter ablation alone on atrial fibrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension, JAMA, 2020; 323(3): 248-255 DOI: 10.1001/jama.2019.21187

Notes to editor

authors:

Maria Simonenko1,2, Petr Fedotov2, Yulia Sazonova2

1EAPC Secondary Prevention and Rehabilitation nucleus member

2Almazov National Medical Research Centre, St. Petersburg, Russia